---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001642"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-09-05T23:59:59+00:00"
generated_at: "2026-05-17T07:57:45.096480+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences closes $3M public offering of common stock and pre-funded warrants

## Summary
- Closed underwritten offering of 640,924 shares at $4.40/share and 40,894 pre-funded warrants at $4.399 each.
- Gross proceeds of ~$3.0 million; underwriter has 45-day option for an additional 102,272 shares.
- Net proceeds to advance preclinical/clinical development of product candidates and for working capital.
- R.F. Lafferty & Co. acted as sole book-running manager; offering closed on September 5, 2025.

## SEC filing metadata
- accession: 0001640334-25-001642
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-09-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001642/0001640334-25-001642-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001642/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001642
- JSON: https://secwatch.observer/filing/0001640334-25-001642.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001642.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.